Pharmaceutical Follow-up Program for Patients with Oral Drug Treatment in Non-small Cell Lung Cancer in a Heterogeneous Health Care System

被引：1
|
作者：
Moreira, G. [1 ]
Ferreira, C. G. [1 ]
Montella, T. [1 ]
Vasconcellos, J. [1 ]
Goncalves, I. [1 ]
机构：
[1] Grp Oncoclin, Rio De Janeiro, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 11期
关键词：
Oral drug; target therapy; clinical pharmacist;
D O I：
10.1016/j.jtho.2019.09.161
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.26
引用
收藏
页码：S1184 / S1184
页数：1
相关论文
共 50 条
  • [41] Systematic postoperative radiologic follow-up in patients with non-small cell lung cancer for detecting second primary lung cancer in stage IA - Discussion
    Holmes, EC
    Grannis
    ARCHIVES OF SURGERY, 2002, 137 (08) : 938 - 939
  • [42] Lorlatinib for the treatment of patients with non-small cell lung cancer
    Akamine, T.
    Toyokawa, G.
    Tagawa, T.
    Yamazaki, K.
    Seto, T.
    Takeo, S.
    Mori, M.
    DRUGS OF TODAY, 2019, 55 (02) : 107 - 116
  • [43] Evaluation and Treatment of Patients with Non-Small Cell Lung Cancer
    Carr, Laurie L.
    Finigan, James H.
    Kern, Jeffrey A.
    MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (06) : 1041 - +
  • [44] Antiangiogenic treatment in patients with non-small cell lung cancer
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2009, 5 : A26 - A31
  • [45] Patterns of follow-up care after curative radiotherapy ± chemotherapy for stage I-III non-small cell lung cancer
    Mohan, Sharanya
    Beydoun, Nadine
    Nasser, Elias
    Nguyen, Andrew
    Shafiq, Jesmin
    Vinod, Shalini
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (03) : 172 - 180
  • [46] Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Besse, B.
    ANNALS OF ONCOLOGY, 2007, 18 : 30 - 31
  • [47] Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    D'Addario, G.
    Felip, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 39 - 40
  • [48] Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    D'Addario, G.
    Felip, E.
    ANNALS OF ONCOLOGY, 2009, 20 : 68 - 70
  • [49] Follow-up Analysis Enhances Understanding of Molecular Residual Disease in Localized Non-Small Cell Lung Cancer
    Zhang, Jia-Tao
    Liu, Si-Yang
    Gao, Xuan
    Liu, Si-Yang Maggie
    Yan, Bingfa
    Huang, Chen
    Jiao, Zicong
    Yan, Hong-Hong
    Pan, Yi
    Dong, Song
    Gao, Wei
    Gong, Yuhua
    Tu, Hai-Yan
    Xia, Xue-Feng
    Zhou, Qing
    Zhong, Wen-Zhao
    Yang, Xue-Ning
    Yi, Xin
    Wu, Yi-Long
    CLINICAL CANCER RESEARCH, 2025, 31 (07) : 1305 - 1314
  • [50] Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer
    Weitberg, AB
    Liu, L
    Yashar, J
    Glicksman, AS
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2001, 20 (03): : 335 - 340
12345